Overview

JD Health is the healthcare business of JD.com and a Hong Kong-listed Chinese digital-health company. Its activities combine internet healthcare services with pharmaceutical and healthcare-product retail. The platform provides consumers with access to medicines, medical supplies, health products, online consultations, prescription-related services, follow-up care, and other digital resources intended to connect healthcare demand with professional and commercial providers. The business originated in 2014, when JD.com's healthcare activities began operating as a standalone business unit. This structure enabled JD to develop healthcare as a distinct vertical rather than treating it solely as an extension of its general e-commerce marketplace. The business attracted investment from Hillhouse Investment among other investors. Its development reflected the broader growth of online healthcare in China, where e-commerce infrastructure, logistics, mobile payments, and rising demand for convenient access to medicines created opportunities for integrated digital health services. JD Health operates across several related areas. Its pharmaceutical retail operations include the JD Pharmacy offering, commonly known as JD Great Pharmacy, through which users can purchase medicines and health products online. The company also operates an internet hospital and provides telemedicine services, allowing users to interact with medical professionals through text, images, voice, and video. Other activities include health management and services connected with prescriptions, follow-up consultations, and hospital appointment arrangements. The company’s model links digital consultation and health information with product fulfillment, although the availability and form of particular services can vary according to regulation, provider participation, and clinical requirements. In August 2020, JD Health introduced JD Family Doctor, a subscription-oriented telemedicine service designed to provide continuous online support for entire families. The service was intended to cover as many as eight family members and offered access to general practitioners, consultations, prescriptions, follow-up visits, and hospital appointment bookings. During the early COVID-19 period, the company reported a sharp increase in online consultations as patients sought alternatives to visiting hospitals; the platform handled more than 100,000 consultations per day at its peak operating periods, with a reported high of 150,000. The family-doctor initiative nevertheless faced difficulties in attracting sufficient users and reaching profitability, while participation by doctors affiliated with public hospitals presented operational challenges. JD Health discontinued the family-doctor division in May 2024. JD Health completed its initial public offering on the Hong Kong Stock Exchange in December 2020 under stock code 6618. The offering raised approximately US$3.5 billion according to the cited reference material. Its shares rose sharply on the first trading day amid strong investor demand. The listing gave JD Health an independent public-market identity while retaining its position within the JD.com group. In June 2023, the company was added as a constituent of the Hang Seng Index. JD Health’s positioning is that of an integrated online healthcare and pharmaceutical platform rather than a pure telemedicine provider or a conventional pharmacy chain. Its principal competitive strengths are associated with JD’s consumer traffic, e-commerce capabilities, fulfillment network, technology infrastructure, and ability to combine healthcare services with product retail. At the same time, the company operates in a highly regulated sector in which prescription rules, medical licensing, professional participation, reimbursement practices, data governance, and pharmaceutical distribution requirements shape its expansion. Its current business therefore centers on a combination of online pharmac…

History

JD Health developed from JD.com's healthcare activities, which began operating as a standalone business unit in 2014. The separation allowed JD to build a specialized healthcare vertical around pharmaceutical retail, medical products, online consultation, and health services. Hillhouse Investment was among the investors associated with the business during its development. The company expanded its role beyond online sales of medicines by building an internet healthcare model. This included online consultations, prescription-related services, follow-up support, hospital appointment assistance, and an internet hospital. The model sought to use JD's e-commerce traffic, digital infrastructure, and logistics capabilities to make medicines and health services more accessible through online channels. Pharmaceutical retail remained a central component, while medical services provided a way to connect users with healthcare professionals. The COVID-19 pandemic accelerated interest in digital medical consultations in China. In early 2020, concerns about visiting hospitals contributed to a significant increase in online consultations on JD Health. The company reported handling over 100,000 consultations daily during the period, with a reported peak of 150,000. The heightened demand encouraged JD Health to develop more structured and continuous forms of digital care. In August 2020, JD Health launched JD Family Doctor. The service was designed to cover whole families, with support for as many as eight members, and offered around-the-clock access to general practitioners through text, image, voice, and video interactions. It also incorporated prescriptions, follow-up consultations, and hospital appointment booking. The initiative was ambitious, with a stated goal of serving 50 million families within five years. In practice, it encountered difficulties in generating sufficient adoption and profitability. The participation of doctors connected with public hospitals also created operational constraints. JD Health ultimately ended the family-doctor division in May 2024. JD Health became a publicly traded company in December 2020 through an initial public offering on the Hong Kong Stock Exchange. The offering raised approximately US$3.5 billion according to the cited reference, making it one of Hong Kong's largest offerings that year. Strong investor demand produced a sharp rise in the share price on the first trading day. The listing established JD Health as a separately traded healthcare company while it continued to operate as JD.com's healthcare unit. The company later gained additional market visibility when it was added to the Hang Seng Index in June 2023. Its business remains focused on the Chinese market and spans online pharmacy, medicines and health products, internet medical services, and health management. JD Health's evolution illustrates both the opportunities and limits of platform-based healthcare: e-commerce and logistics can improve access to products, while clinical services remain dependent on regulation, licensed professionals, hospital relationships, and sustainable economics.

2024
Family-doctor division discontinued
[1]JD Health - Wikipediaen.wikipedia.org
JD Health discontinued JD Family Doctor after the service struggled to gain traction and profitability.
2023
Added to the Hang Seng Index
[1]JD Health - Wikipediaen.wikipedia.org
JD Health became a constituent of the Hang Seng Index.
2020
JD Family Doctor launches
[1]JD Health - Wikipediaen.wikipedia.org
JD Health introduced a family telemedicine service offering consultations and related care support for households of up to eight members.
2020
Hong Kong listing
[1]JD Health - Wikipediaen.wikipedia.org
JD Health completed its initial public offering and began trading on the Hong Kong Stock Exchange under ticker 6618.
2014
Healthcare business becomes a standalone JD unit
[1]JD Health - Wikipediaen.wikipedia.org
JD.com's healthcare activities began operating as a standalone business unit, forming the foundation of JD Health.

Products and positioning

An integrated Chinese online healthcare platform combining pharmaceutical e-commerce, telemedicine, internet hospital services, and health-management resources.

Online pharmacy
JD Great Pharmacy
JD Health's online pharmacy offering provides digital access to medicines and health-related products through JD's e-commerce infrastructure. It represents the retail foundation of the company's business and connects product discovery, ordering, and fulfillment with the broader JD ecosystem. Specific product availability and prescription processes are subject to applicable Chinese healthcare and pharmaceutical regulations.
Internet hospital
JD Health Internet Hospital
The JD Health Internet Hospital supports online medical interactions and related digital healthcare services. Its service model includes consultation capabilities and may connect medical advice with prescriptions, follow-up care, and hospital appointment support where permitted. It forms part of JD Health's effort to integrate clinical services with online pharmaceutical and health-product retail.
Telemedicine subscription service · 2020
JD Family Doctor
JD Family Doctor was a family-oriented telemedicine service launched in August 2020. It was designed to cover up to eight family members and offered continuous access to general practitioners through text, image, voice, and video consultations, together with prescriptions, follow-ups, and hospital appointment bookings. The division was discontinued in May 2024.

Controversies

2022
Source

Brand decisions

2024
Discontinuation of JD Family DoctorStrategy
Background
The family-doctor initiative faced weak traction, limited profitability, and difficulties associated with securing participation from doctors affiliated with public hospitals.
Action taken
JD Health discontinued the family-doctor division in May 2024.
Aftermath
The decision reduced JD Health's emphasis on that specific subscription telemedicine model while leaving its broader online pharmacy and digital healthcare activities in place.
Source
2020
Launch of JD Family DoctorProduct launch
Background
JD Health sought to extend its online healthcare model from transactional medicine and product retail toward continuous family medical support.
Action taken
It launched a telemedicine service for households of up to eight people, including general-practitioner access, digital consultations, prescriptions, follow-up visits, and hospital appointment booking.
Aftermath
The service struggled to achieve sufficient adoption and profitability and was discontinued in May 2024.
Source
2020
Initial public offering in Hong KongM&A
Background
JD Health pursued a public listing as its healthcare operations developed into a substantial standalone business within the JD.com group.
Action taken
The company completed an initial public offering on the Hong Kong Stock Exchange in December 2020 under ticker 6618.
Aftermath
The offering reportedly raised approximately US$3.5 billion, and the shares rose sharply on their first trading day.
IPO proceeds. Approximately US$3.5 billion raised (December 2020 IPO)
Source

Recent events

Unconfirmed
JD Health checkup center renamed JD Health General Clinic[9]京东健康体检中心正式更名为京东健康综合门诊163.com
Reported: 2026-08-13
JD Health's checkup center was officially renamed JD Health General Clinic, integrating JD checkup, JD medical aesthetics and JD dental services into one-stop health management.
2022-01-09
JD Health launches New Year goods festival[10]京东健康年货节正式启动tech.china.com
JD Health launched its New Year goods festival on the evening of January 9, offering discounts and other promotions and featuring health-related products and customized gift boxes.
2021-11-19
JD Health and Wuxi Mental Health Center launch an online service zone[11]京东健康与无锡市精神卫生中心上线服务专区finance.jrj.com.cn
JD Health and Wuxi Mental Health Center launched an online service zone for mental health services on JD Health. The service offers online follow-up consultations, remote consultations, online training and expert-team consultations.
2021-09-06
JD.com announces executive appointments at JD Group and JD Health[12]京东宣布集团及京东健康管理层任命finance.sina.com.cn
Reported: 2021-09-06
JD.com announced that Xu Lei was promoted to president of JD Group, Xin Lijun would become CEO of JD Retail, and Jin Enlin would become CEO of JD Health. The report also said JD Health director Zhang Peng resigned as a non-executive director and compensation committee member, and Xu Ran succeeded her on the committee, effective September 6.
Unconfirmed
JD Health launches internet outpatient insurance service[13]京东健康推出互联网门诊险服务finance.jrj.com.cn
JD Health and JD Allianz Insurance launched an internet outpatient insurance service that connects online medical consultations, medicine delivery and direct insurance claims; eligible medicine costs are reimbursed at 70%.
Unconfirmed
So-Young Technology and JD Health sign strategic partnership[14]新氧科技与京东健康签订战略合作协议blog.eastmoney.com
So-Young Technology and JD Health signed a strategic partnership agreement to explore internet-based medical-aesthetics models and promote greater transparency and connectivity in the industry.
Unconfirmed
AstraZeneca opens a flagship store on JD Health[15]阿斯利康在京东健康开设自营旗舰店finance.sina.com.cn
Reported: 2021-06-20
AstraZeneca opened its self-operated flagship store on JD Health, expanding the companies' online health-service cooperation.
2021-06-01
JD Health and Sanofi China upgrade strategic cooperation[16]京东健康与赛诺菲中国升级战略合作finance.sina.com.cn
Reported: 2021-06-01
JD Health and Sanofi China announced an upgraded strategic cooperation in digital healthcare, including work on an integrated digital solution for online diagnosis and treatment and health management for patients with chronic diseases.
2021-05-08
JD Health and Beiyi Tairan form strategic partnership[17]京东健康与北医泰然达成战略合作finance.sina.com.cn
Reported: 2021-05-08
JD Health and Beiyi Tairan formed a strategic partnership to build an integrated online and offline service model for men's health.
2021-05-08
JD Health and insurers launch Jia Yibao managed health insurance service[18]京东健康与保险公司推出“家医保”管理型健康险服务news.cnfol.com
JD Health, Fosun United Health Insurance, JD Allianz Insurance and other insurers jointly launched Jia Yibao, a managed health insurance service combining insurance protection with JD Health medical and health-management services for families.

Showing the 10 most recent.

Related entries

JD.com